Fundz

Deverra Therapeutics is looking to raise $15,000

Apr 26, 2024•about 2 years ago

Target Amount

$15,000

Deadline

Jul 01, 2024

CIK0001822782
File Number007-00007

Issuer Information

Issuer

Deverra Therapeutics

Location

1600 fairview avenue east

seattle, washington, united states

About

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C/A)
Target Amount$15,000
Securities TypeCommon Stock

Campaign Ended

Ended 698 days ago

PlatformStartEngine Capital, LLC
View SEC Filing

Related People

Choose your plan to reveal verified contacts